Loading

Weekly Newsletter

Friday, September 19, 2025

News

Recognizing an Industry-leading Vision to Foster Rehab Care at Scale

Lifepoint Rehabilitation, a business unit of Lifepoint Health, has officially secured recognition for 31 of its freestanding inpatient rehabilitation facilities and 19 of its contracted acute rehabilitation units, awarded by Newsweek, in this year’s list of America’s Best Physical...

Fostering Collaboration to Drive a Performance Uptick Within Pharma Manufacturing Space

Senderra Specialty Pharmacy has officially announced the launch of Pharma Navigator, which happens to be a groundbreaking digital platform geared towards strengthening collaboration between pharmaceutical manufacturers and Senderra. According to certain reports, this particular technology is well-equipped to deliver, at...

Simplifying the Regulatory Side of a Pharmaceutical Operation

Elsevier, a global information and analytics company, has officially announced the launch of PharmaPendium AI, which happens to be a generative AI assistant for regulatory intelligence in drug development. According to certain reports, the stated assistant arrives bearing an ability...

A Billion Dollar Deal to Land One of the Most Promising Therapeutic for MDD

AbbVie has officially announced a strategic partnership with Gilgamesh Pharmaceuticals Inc Under the agreed terms, AbbVie will acquire Gilgamesh's lead investigational candidate i.e. Bretisilocin, which is currently in clinical development for the treatment of patients with moderate-to-severe major depressive disorder...

Innovators

Recognizing an Industry-leading Vision to Foster Rehab Care at Scale

Lifepoint Rehabilitation, a business unit of Lifepoint Health, has officially secured recognition for 31 of its freestanding inpatient rehabilitation facilities and 19 of its contracted acute rehabilitation units, awarded by Newsweek, in this year’s list of America’s Best Physical...

Fostering Collaboration to Drive a Performance Uptick Within Pharma Manufacturing Space

Senderra Specialty Pharmacy has officially announced the launch of Pharma Navigator, which happens to be a groundbreaking digital platform geared towards strengthening collaboration between pharmaceutical manufacturers and Senderra. According to certain reports, this particular technology is well-equipped to deliver, at...

Simplifying the Regulatory Side of a Pharmaceutical Operation

Elsevier, a global information and analytics company, has officially announced the launch of PharmaPendium AI, which happens to be a generative AI assistant for regulatory intelligence in drug development. According to certain reports, the stated assistant arrives bearing an ability...

A Billion Dollar Deal to Land One of the Most Promising Therapeutic for MDD

AbbVie has officially announced a strategic partnership with Gilgamesh Pharmaceuticals Inc Under the agreed terms, AbbVie will acquire Gilgamesh's lead investigational candidate i.e. Bretisilocin, which is currently in clinical development for the treatment of patients with moderate-to-severe major depressive disorder...

Insights

Recognizing an Industry-leading Vision to Foster Rehab Care at Scale

Lifepoint Rehabilitation, a business unit of Lifepoint Health, has officially secured recognition for 31 of its freestanding inpatient rehabilitation facilities and 19 of its contracted acute rehabilitation units, awarded by Newsweek, in this year’s list of America’s Best Physical...

Fostering Collaboration to Drive a Performance Uptick Within Pharma Manufacturing Space

Senderra Specialty Pharmacy has officially announced the launch of Pharma Navigator, which happens to be a groundbreaking digital platform geared towards strengthening collaboration between pharmaceutical manufacturers and Senderra. According to certain reports, this particular technology is well-equipped to deliver, at...

Simplifying the Regulatory Side of a Pharmaceutical Operation

Elsevier, a global information and analytics company, has officially announced the launch of PharmaPendium AI, which happens to be a generative AI assistant for regulatory intelligence in drug development. According to certain reports, the stated assistant arrives bearing an ability...

A Billion Dollar Deal to Land One of the Most Promising Therapeutic for MDD

AbbVie has officially announced a strategic partnership with Gilgamesh Pharmaceuticals Inc Under the agreed terms, AbbVie will acquire Gilgamesh's lead investigational candidate i.e. Bretisilocin, which is currently in clinical development for the treatment of patients with moderate-to-severe major depressive disorder...